Bone Marrow Transplant Unit: An Expensive but Necessary Battle

By: Su-Mei Chang, Center for Technology and Humanities

A three-year-old boy in southern Taiwan urgently needed a bone marrow transplant for severe aplastic anemia. Because he could not be admitted to a bone marrow transplant (BMT) unit in time, life-saving treatment was delayed, and his young life came to an early end. As public attention turns to the uneven distribution of healthcare resources between northern and southern Taiwan, an unavoidable question emerges: why are bone marrow transplant units so scarce?

A High-Isolation “Battlefield”

In modern medicine, hematopoietic stem cell transplantation (HSCT), commonly referred to as a bone marrow transplant, is often viewed as a last remaining source of hope. For patients with blood cancers such as acute leukemia and lymphoma, it is not simply another treatment option. For many, it is a chance to start over.

But building and sustaining a BMT unit is far more difficult than most people realize. Transplant patients must first receive high-dose chemotherapy or radiation to essentially “wipe out” the body’s blood-forming function. Only then are healthy stem cells infused to rebuild the blood and immune system. During the window when immunity is close to zero, any infection can be fatal, including bacteria, fungi, and even airborne dust spores.

That is why a qualified BMT unit requires near operating-room-level standards, including positive-pressure ventilation, sterile filtration, and strict control of entry and exit. The environment must be designed to reduce exposure to pathogens as much as possible, because the patient’s body cannot defend itself.

Care That Demands ICU-Level Staffing

Transplant care is also labor-intensive and technically demanding. From central venous catheter management and complex antibiotic regimens to monitoring drug levels in the bloodstream, every step requires specialized training and constant vigilance. Nurse-to-patient ratios are often close to ICU standards, and specialized nurses must be able to respond to severe infections and sudden clinical deterioration.

In recent years, shortages of pediatric subspecialists and experienced nursing staff have made expansion and operation of BMT units even more challenging.

Why Only a Few Hospitals Can Do It

A bone marrow transplant is not something one department can deliver alone. It is the product of true multidisciplinary coordination. Teams in hematology-oncology, infectious disease, pharmacy, pathology and laboratory medicine, nutrition, rehabilitation, and psychological counseling must work tightly together to manage complications that can arise at any time. Without a fully developed multidisciplinary platform, even an expensive isolation ward may not be enough to deliver safe, effective transplant care.

A second, very practical barrier is case volume. Transplant medicine depends on accumulated experience. If the number of cases is too small, hospitals struggle to sustain the high costs, and clinical teams cannot maintain long-term readiness and expertise. This is one reason BMT units in Taiwan tend to be concentrated in a limited number of large medical centers or specialized hospitals.

KFSYSCC’s Commitment and Track Record

Since establishing its bone marrow transplant team, the Koo Foundation Sun Yat-Sen Cancer Center (KFSYSCC) has treated more than 500 transplant cases. The center maintains a stable annual volume of about 25 to 35 cases per year, including approximately 5 to 10 pediatric cases annually.

Transplant types performed include autologous transplants, allogeneic transplants from related and unrelated donors, cord blood transplants, and haploidentical (half-matched) transplants. Patients treated include those with acute leukemia, lymphoma, multiple myeloma, and selected benign or inherited conditions. Through careful planning and close multidisciplinary collaboration, many patients have achieved long-term, relapse-free outcomes, reflecting KFSYSCC’s ability to align its clinical practice with international standards.

Dr. Rong-Long Chen: A Key Force in Pediatric Transplant Care

Within KFSYSCC’s pediatric transplant team, Dr. Rong-Long Chen, an attending physician in hematology-oncology and the team convener, has led the group through cases that often feel nearly impossible: relapsed childhood blood cancers, rare congenital neurological disorders, and even uncommon secondary histiocytic sarcoma. Each decision can be agonizing, shaped by a reality that feels stark: attempting treatment may fail, but doing nothing may leave no chance at all. In these stories, some children endured the transplant process and survived, allowing life to continue.

Dr. Chen’s professional career spans more than 40 years. Early on, he dedicated himself to research in hematologic cellular therapy and also pursued training in the United States. After returning to Taiwan, he brought clinical experience and research insight into strengthening KFSYSCC’s hematopoietic stem cell transplant program, introducing newer approaches while building a complete, team-based transplant platform.

Dr. Chen emphasizes that bone marrow transplantation is not only a technical breakthrough. It is a long, sustained struggle against disease and against time. KFSYSCC currently operates six acute BMT isolation beds, with facility design informed by the concepts and spirit of Duke University’s transplant unit. Combined with the expertise of its multidisciplinary blood and marrow transplant team, KFSYSCC aims to provide each patient with comprehensive care and an individualized treatment plan.